Interrelationship Of Runx2 and estrogen pathway in skeletal tissues

BMB Reports

Volumn 44, Issue 10, 2011, Pages 613-618

  Jeong, Jae Hwan ^a   Choi, Je Yong ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Aromatase; Estrogen pathway; Runx2

Indexed keywords

AROMATASE; ESTROGEN; TRANSCRIPTION FACTOR RUNX2;

BONE; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; SHORT SURVEY; SIGNAL TRANSDUCTION;

AROMATASE; BONE AND BONES; CORE BINDING FACTOR ALPHA 1 SUBUNIT; ESTROGENS; SIGNAL TRANSDUCTION;

EID: 84863234764     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2011.44.10.613     Document Type: Short Survey

References (58)

1. Khosla, S., Westendorf, J. J. and Oursler, M. J. (2008) Building bone to reverse osteoporosis and repair fractures. J. Clin. Invest. 118, 421-428.
2. Stein, G. S., Lian, J. B., van Wijnen, A. J., Stein, J. L., Montecino, M., Javed, A., Zaidi, S. K., Young, D. W., Choi, J. Y. and Pockwinse, S. M. (2004) Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 23, 4315-4329.
3. Choi, J. Y., Pratap, J., Javed, A., Zaidi, S. K., Xing, L., Balint, E., Dalamangas, S., Boyce, B., van Wijnen, A. J., Lian, J. B., Stein, J. L., Jones, S. N. and Stein, G. S. (2001) Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc. Natl. Acad. Sci. U.S.A. 98, 8650-8655.
4. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y. H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S. and Kishimoto, T. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764.
5. Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., Stamp, G. W., Beddington, R. S., Mundlos, S., Olsen, B. R., Selby, P. B. and Owen, M. J. (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771.
6. Banerjee, C., McCabe, L. R., Choi, J. Y., Hiebert, S. W., Stein, J. L., Stein, G. S. and Lian, J. B. (1997) Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J. Cell. Biochem. 66, 1-8.
7. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. and Karsenty, G. (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754.
8. Javed, A., Barnes, G. L., Jasanya, B. O., Stein, J. L., Gerstenfeld, L., Lian, J. B. and Stein, G. S. (2001) runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins. Mol. Cell. Biol. 21, 2891-2905.
9. Pratap, J., Javed, A., Languino, L. R., van Wijnen, A. J., Stein, J. L., Stein, G. S. and Lian, J. B. (2005) The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol. Cell. Biol. 25, 8581-8591.
10. Zaidi, S. K., Javed, A., Choi, J. Y., van Wijnen, A. J., Stein, J. L., Lian, J. B. and Stein, G. S. (2001) A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J. Cell Sci. 114, 3093-3102.
11. Han, M. S., Kim, H. J., Wee, H. J., Lim, K. E., Park, N. R., Bae, S. C., van Wijnen, A. J., Stein, J. L., Lian, J. B., Stein, G. S. and Choi, J. Y. (2010) The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-beta. J. Cell. Biochem. 110, 97-103.
12. Kim, H. J., Nam, S. H., Kim, H. J., Park, H. S., Ryoo, H. M., Kim, S. Y., Cho, T. J., Kim, S. G., Bae, S. C., Kim, I. S., Stein, J. L., van Wijnen, A. J., Stein, G. S., Lian, J. B. and Choi, J. Y. (2006) Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype. J. Cell. Physiol. 207, 114-122.
13. Mundlos, S., Otto, F., Mundlos, C., Mulliken, J. B., Aylsworth, A. S., Albright, S., Lindhout, D., Cole, W. G., Henn, W., Knoll, J. H., Owen, M. J., Mertelsmann, R., Zabel, B. U. and Olsen, B. R. (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773-779.
14. Pratap, J., Wixted, J. J., Gaur, T., Zaidi, S. K., Dobson, J., Gokul, K. D., Hussain, S., van Wijnen, A. J., Stein, J. L., Stein, G. S. and Lian, J. B. (2008) Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res. 68, 7795-7802.
15. Zheng, Q., Zhou, G., Morello, R., Chen, Y., Garcia-Rojas, X. and Lee, B. (2003) Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J. Cell Biol. 162, 833-842.
16. Maruyama, Z., Yoshida, C. A., Furuichi, T., Amizuka, N., Ito, M., Fukuyama, R., Miyazaki, T., Kitaura, H., Nakamura, K., Fujita, T., Kanatani, N., Moriishi, T., Yamana, K., Liu, W., Kawaguchi, H., Nakamura, K. and Komori, T. (2007) Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev. Dyn. 236, 1876-1890.
17. Syed, F. and Khosla, S. (2005) Mechanisms of sex steroid effects on bone. Biochem. Biophys. Res. Commun. 328, 688-696.
18. Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K. S. and Simpson, E. R. (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337, 91-95.
19. Deladoey, J., Fluck, C., Bex, M., Yoshimura, N., Harada, N. and Mullis, P. E. (1999) Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy. J. Clin. Endocrinol. Metab. 84, 4050-4054.
20. Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C. and Qin, K. (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80, 3689-3698.
21. Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B. and Korach, K. S. (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331, 1056-1061.
22. Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., Nishina, H., Takeda, S., Takayanagi, H., Metzger, D., Kanno, J., Takaoka, K., Martin, T. J., Chambon, P. and Kato, S. (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811-823.
23. Martin-Millan, M., Almeida, M., Ambrogini, E., Han, L., Zhao, H., Weinstein, R. S., Jilka, R. L., O'Brien, C. A. and Manolagas, S. C. (2010) The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol. Endocrinol. 24, 323-334.
24. Park, H., Jung, Y. K., Park, O. J., Lee, Y. J., Choi, J. Y. and Choi, Y. (2005) Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis. J. Immunol. 175, 7193-7201.
25. Krum, S. A., Miranda-Carboni, G. A., Hauschka, P. V., Carroll, J. S., Lane, T. F., Freedman, L. P. and Brown, M. (2008) Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J. 27, 535-545.
26. Zallone, A. (2006) Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann. N. Y. Acad. Sci. 1068, 173-179.
27. Jones, M. E., Boon, W. C., Proietto, J. and Simpson, E. R. (2006) Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol. Metab. 17, 55-64.
28. Bulun, S. E., Sebastian, S., Takayama, K., Suzuki, T., Sasano, H. and Shozu, M. (2003) The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J. Steroid Biochem. Mol. Biol. 86, 219-224.
29. Simpson, E. R., Clyne, C., Rubin, G., Boon, W. C., Robertson, K., Britt, K., Speed, C. and Jones, M. (2002) Aromatase-a brief overview. Annu. Rev. Physiol. 64, 93-127.
30. Simpson, E. R., Mahendroo, M. S., Means, G. D., Kilgore, M. W., Hinshelwood, M. M., Graham-Lorence, S., Amarneh, B., Ito, Y., Fisher, C. R., Michael, M. D., Mendelson, C. R. and Bulun, S. E. (1994) Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 15, 342-355.
31. Hinshelwood, M. M., Smith, M. E., Murry, B. A. and Mendelson, C. R. (2000) A 278 bp region just upstream of the human CYP19 (aromatase) gene mediates ovary-specific expression in transgenic mice. Endocrinology 141, 2050-2053.
32. Mahendroo, M. S., Means, G. D., Mendelson, C. R. and Simpson, E. R. (1991) Tissue-specific expression of human P-450 AROM. The promoter responsible for expression in adipose tissue is different from that utilized in placenta. J. Biol. Chem. 266, 11276-11281.
33. Mahendroo, M. S., Mendelson, C. R. and Simpson, E. R. (1993) Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J. Biol. Chem. 268, 19463-19470.
34. Zhao, Y., Mendelson, C. R. and Simpson, E. R. (1995) Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes. Mol. Endocrinol. 9, 340-349.
35. Pezzi, V., Mathis, J. M., Rainey, W. E. and Carr, B. R. (2003) Profiling transcript levels for steroidogenic enzymes in fetal tissues. J. Steroid Biochem. Mol. Biol. 87, 181-189.
36. Nawata, H., Tanaka, S., Tanaka, S., Takayanagi, R., Sakai, Y., Yanase, T., Ikuyama, S. and Haji, M. (1995) Aromatase in bone cell: association with osteoporosis in postmenopausal women. J. Steroid Biochem. Mol. Biol. 53, 165-174.
37. Oz, O. K., Millsaps, R., Welch, R., Birch, J. and Zerwekh, J. E. (2001) Expression of aromatase in the human growth plate. J. Mol. Endocrinol. 27, 249-253.
38. Sasano, H., Uzuki, M., Sawai, T., Nagura, H., Matsunaga, G., Kashimoto, O. and Harada, N. (1997) Aromatase in human bone tissue. J. Bone Miner Res. 12, 1416-1423.
39. Shozu, M. and Simpson, E. R. (1998) Aromatase expression of human osteoblast-like cells. Mol. Cell. Endocrinol. 139, 117-129.
40. Tanaka, S., Haji, M., Nishi, Y., Yanase, T., Takayanagi, R. and Nawata, H. (1993) Aromatase activity in human osteoblast-like osteosarcoma cell. Calcif. Tissue Int. 52, 107-109.
41. Sjogren, K., Lagerquist, M., Moverare-Skrtic, S., Andersson, N., Windahl, S. H., Swanson, C., Mohan, S., Poutanen, M. and Ohlsson, C. (2009) Elevated aromatase expression in osteoblasts leads to increased bone mass without systemic adverse effects. J. Bone Miner Res. 24, 1263-1270.
42. Lea, C. K., Ebrahim, H., Tennant, S. and Flanagan, A. M. (1997) Aromatase cytochrome P450 transcripts are detected in fractured human bone but not in normal skeletal tissue. Bone 21, 433-440.
43. Shozu, M., Zhao, Y. and Simpson, E. R. (2000) TGF-beta1 stimulates expression of the aromatase (CYP19) gene in human osteoblast-like cells and THP-1 cells. Mol. Cell. Endocrinol. 160, 123-133.
44. Watanabe, M., Ohno, S. and Nakajin, S. (2005) Forskolin and dexamethasone synergistically induce aromatase (CYP19) expression in the human osteoblastic cell line SV-HFO. Eur. J. Endocrinol. 152, 619-624.
45. Watanabe, M., Simpson, E. R., Pathirage, N., Nakajin, S. and Clyne, C. D. (2004) Aromatase expression in the human fetal osteoblastic cell line SV-HFO. J. Mol. Endocrinol. 32, 533-545.
46. Morioka, M., Shimodaira, K., Kuwano, Y., Fujikawa, H., Saito, H. and Yanaihara, T. (2000) Effect of interleukin-1beta on aromatase activity and cell proliferation in human osteoblast-like cells (HOS). Biochem. Biophys. Res. Commun. 268, 60-64.
47. Enjuanes, A., Garcia-Giralt, N., Supervia, A., Nogues, X., Mellibovsky, L., Carbonell, J., Grinberg, D., Balcells, S. and Diez-Perez, A. (2003) Regulation of CYP19 gene expression in primary human osteoblasts: effects of vitamin D and other treatments. Eur. J. Endocrinol. 148, 519-526.
48. Tanaka, S., Haji, M., Takayanagi, R., Tanaka, S., Sugioka, Y. and Nawata, H. (1996) 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts. Endocrinology 137, 1860-1869.
49. Jeong, J. H., Jung, Y. K., Kim, H. J., Jin, J. S., Kim, H. N., Kang, S. M., Kim, S. Y., van Wijnen, A. J., Stein, J. L., Lian, J. B., Stein, G. S., Kato, S. and Choi, J. Y. (2010) The gene for aromatase, a rate-limiting enzyme for local estrogen biosynthesis, is a downstream target gene of Runx2 in skeletal tissues. Mol. Cell. Biol. 30, 2365-2375.
50. Miyaura, C., Toda, K., Inada, M., Ohshiba, T., Matsumoto, C., Okada, T., Ito, M., Shizuta, Y. and Ito, A. (2001) Sex- and age-related response to aromatase deficiency in bone. Biochem. Biophys. Res. Commun. 280, 1062-1068.
51. Oz, O. K., Hirasawa, G., Lawson, J., Nanu, L., Constantinescu, A., Antich, P. P., Mason, R. P., Tsyganov, E., Parkey, R. W., Zerwekh, J. E. and Simpson, E. R. (2001) Bone phenotype of the aromatase deficient mouse. J. Steroid Biochem. Mol. Biol. 79, 49-59.
52. Oz, O. K., Zerwekh, J. E., Fisher, C., Graves, K., Nanu, L., Millsaps, R. and Simpson, E. R. (2000) Bone has a sexually dimorphic response to aromatase deficiency. J. Bone Miner Res. 15, 507-514.
53. Phillips, J. E., Gersbach, C. A., Wojtowicz, A. M. and Garcia, A. J. (2006) Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J. Cell Sci. 119, 581-591.
54. Paredes, R., Arriagada, G., Cruzat, F., Villagra, A., Olate, J., Zaidi, K., van Wijnen, A., Lian, J. B., Stein, G. S., Stein, J. L. and Montecino, M. (2004) Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol. Cell. Biol. 24, 8847-8861.
55. Khalid, O., Baniwal, S. K., Purcell, D. J., Leclerc, N., Gabet, Y., Stallcup, M. R., Coetzee, G. A. and Frenkel, B. (2008) Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer. Endocrinology 149, 5984-5995.
56. Teplyuk, N. M., Galindo, M., Teplyuk, V. I., Pratap, J., Young, D. W., Lapointe, D., Javed, A., Stein, J. L., Lian, J. B., Stein, G. S. and van Wijnen, A. J. (2008) Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors. J. Biol. Chem. 283, 27585-27597.
57. Teplyuk, N. M., Zhang, Y., Lou, Y., Hawse, J. R., Hassan, M. Q., Teplyuk, V. I., Pratap, J., Galindo, M., Stein, J. L., Stein, G. S., Lian, J. B. and van Wijnen, A. J. (2009) The osteogenic transcription factor runx2 controls genes involved in sterol/ steroid metabolism, including CYP11A1 in osteoblasts. Mol. Endocrinol. 23, 849-861.
58. Jeong, J. H., Jin, J. S., Kim, H. N., Kang, S. M., Liu, J. C., Lengner, C. J., Otto, F., Mundlos, S., Stein, J. L., van Wijnen, A. J., Lian, J. B., Stein, G. S. and Choi, J. Y. (2008) Expression of Runx2 transcription factor in non-skeletal tissues, sperm and brain. J. Cell. Physiol. 217, 511-517.